PlainRecalls
FDA Drug Moderate Class II Terminated

Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41

Reported: October 27, 2021 Initiated: September 10, 2021 #D-0019-2022

Product Description

Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41

Reason for Recall

Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"

Details

Units Affected
100 glass vials
Distribution
Nationwide within the United States
Location
Bethlehem, PA

Frequently Asked Questions

What product was recalled?
Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41. Recalled by Piramal Critical Care, Inc.. Units affected: 100 glass vials.
Why was this product recalled?
Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"
Which agency issued this recall?
This recall was issued by the FDA Drug on October 27, 2021. Severity: Moderate. Recall number: D-0019-2022.